Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 12, 2009, Pages 1699-1707

  Zeng, Huawu ^a   Liu, Xiaohua ^a   Dou, Shengshan ^a   Xu, Wen ^b   Li, Na ^a   Liu, Xiaojun ^a   Zhang, Weidong ^a,c   Hu, Zhenlin ^a   Liu, Runhui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemotactic factors; Huang Lian Jie Du Tang (HLJDT); Inducible nitric oxide synthase; Lipoxygenase; Nitric oxide

Indexed keywords

11 HYDROXYICOSATETRAENOIC ACID; 12 HYDROXY 5,8,10 HEPTADECATRIENOIC ACID; 12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID DERIVATIVE; BETA ACTIN; CALCIMYCIN; CHINESE DRUG; CXCL2 CHEMOKINE; HUANG LIAN JIE DU TANG; ICOSANOID; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE B4; LIPOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN B2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; RANTES; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RAT; TANDEM MASS SPECTROMETRY;

EID: 75749094818     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.12.0016     Document Type: Article

References (35)

1. Dai Y et al. Suppression of neuropeptides' mRNA expression by herbal medicines in a rat model of peripheral inflammation. Life Sci 2000; 66: 19-29.
2. Gao XK et al. Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid Based Complement Alternat Med 2005; 2: 191-199.
3. Arakawa K et al. Improvement of accessory symptoms of hypertension by TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-Medicine Granules for ethical use: a double-blind, placebo-controlled study. Phytomedicine 2006; 13: 1-10.
4. Miura N et al. An herbal medicine orengedokuto prevents indomethacin-induced enteropathy. Biol Pharm Bull 2007; 30: 495-501.
5. Fukutake M et al. Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats. Cancer Lett 2000; 157: 9-14.
6. Gordon S. The role of the macrophage in immune regulation. Res Immunol 1998; 149: 685-688.
7. Wang LM, Mineshita S. Preventive effects of unsei-in and oren-gedoku-to, Chinese traditional medicines, against rat paw oedema and abdominal constriction in mice. J Pharm Pharmacol 1996; 48: 327-331.
8. Zhou H, Mineshita S. The effect of Oren-gedoku-to on experimental colitis in rats. J Pharm Pharmacol 1999; 51: 1065-1074.
9. Wang LM et al. Effects of oren-gedoku-to and unsei-in, Chinese traditional medicines, on interleukin-8 and superoxide dismutase in rats. J Pharm Pharmacol 1997; 49: 102-104.
10. You KM et al. Inhibition of cyclooxygenase/lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch Pharm Res 1999; 22: 18-24.
11. Burnett BP et al. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food 2007; 10: 442-451.
12. Somjen D et al. Lipoxygenase metabolites are mediators of PTH-dependent human osteoblast growth. Bone 2008; 42: 491-497.
13. Dou SS et al. Chromatographic fingerprinting and quantitative analysis for the quality evaluation of Huang-Lian-Jie-Du-Tang by HPLC-DAD and HPLC-ESI-MS. Chromatographia (DOI:10.1365/s10337-008-0945-3 2009)
14. Rouzer CA et al. RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-a secretion. J Lipid Res 2005; 46: 1027-1037.
15. Ishida-Fujii K et al. Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5. Biosci Biotechnol Biochem 2007; 71: 866-873.
16. Margalit A et al. Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. Anal Biochem 1996; 235: 73-81.
17. Yang K et al. Finding multiple target optimal intervention in disease-related molecular network. Mol Syst Biol 2008; 4: 228.
18. -ΔΔCT method. Methods 2001; 25: 402-408.
19. Korhonen R et al. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 471-479.
20. Hwang YS et al. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci 2002; 71: 2105-2017.
21. Ohta Y et al. Preventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in rats. J Ethnopharmacol 1999; 67: 377-384.
22. Spector AA et al. Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 1988; 27: 271-323.
23. Yang XW et al. Anti-inflammatory and anti-tumour effects of Abies georgei extracts. J Pharm Pharmacol 2008; 60: 937-941.
24. Myers RF, Siegel MI. Differential effects of anti-inflammatory drugs on lipoxygenase and cyclo-oxygenase activities of neutrophils from a reverse passive Arthus reaction. Biochem Biophys Res Commun 1983; 112: 586-594.
25. Bailey JM et al. Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells. J Lipid Res 1983; 24: 1419-1428.
26. Kozak KR et al. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 2000; 275: 33744-33749.
27. Wallace JL et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 1998; 115: 101-109.
28. Salvemini D et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996; 118: 829-838.
29. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445.
30. Viola A, Luster AD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 2008; 48: 171-197.
31. Weinberg JB. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunol Res 2000; 22: 319-341.
32. Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages. Pharmacol Toxicol 1999; 84: 288-291.
33. Nakajima T et al. Inhibitory effect of baicalein, a flavonoid in scutellaria root, on eotaxin production by human dermal fibroblasts. Planta Med 2001; 67: 132-135.
34. Chang YL et al. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001; 60: 507-513.
35. Chen YC et al. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001; 61: 1417-1427.